Web Site : http://www.biotrace.co.uk/

Company Fact Sheet : http://www.biotrace.co.uk/uploads/documents/135.pdf

http://news.ft.com/cms/s/dd75f814-c0a3-11da-9419-0000779e2340.html

John Lee: A fine month to reel them in By John Lee Published: March 31 2006

""""Finally to Marchs new find industrial microbiology products manufacturer Biotrace International a rare Welsh stock.

I was surprised to discover this solid quality niche business in the attractive growth sector of equipment for the rapid testing of microbial contamination in the food/beverage industry, also operating in the defence field, and planning to expand into pharmaceuticals and personal care products on a prospective price/earnings ratio only just in double figures.

Further research revealed it to be cash generative, with good gross margins, and with substantially recurring revenues. Additionally the recent results statement generated optimism and the tie-up with the large US filtration company Pall Corporation augurs well.

In the past Biotrace clearly traded on a much higher rating but had drifted to what I judged to be an attractive level. Thus I have been recently buying between 87p and 97p in a fairly tight market its market capitalisation is just less than 40m. Despite a lowish yield, this is one to tuck away in my Peps and Isas. """""

Latest Broker Forecasts :

Rowan Dartington 18th Apr 2006 HOLD
2006 Pre Tax Profit 4.4M
2006 EPS 7.27p
2006 Div 1.7p

2007 Pre Tax Profit 4.8M
2007 EPS 7.98p
2007 DIV 1.85p


Teather and Greenwood 4th April 2006 HOLD
2006 Pre Tax Profit 4.5M
2006 EPS 8.1p
2006 Div 1.9p

2007 PTP
2007 EPS
207 DIV


Numis 31st March 2006 BUY
2006 Pre Tax Profit 4.1M
2006 EPS 8.5p
2006 DIV 1.7p

2007 Pre Tax Profit 5.2M
2007 EPS 9.7p
2007 DIV 1.8p

Biotrace receives several 'preliminary' approaches

By Robert Orr

Published: September 16 2006 03:00 | Last updated: September 16 2006 03:00

Biotrace International, the Welsh germ detection company, has received a number of approaches from prospective buyers for the company whose client list includes food and drink groups such as Nestl Kraft and Pepsi.

Biotrace and Numis Securities, its advisers, are studying the various proposals, received in the last few months and understood to be in the region of 130p a share.

Offer now made, 130p in cash.

Easy money these takeovers :)

Now I await the offer for EKA to come in, which should, I hope, be a fair few points higher than todays EKA price (I expect something around 120p to 130p equivalent but an all share offer).

Am I right in saying that this company was taken over by 3M, yet is still showing as paying a divi (as BOI) on the 26th Oct (6.6875p)?